We can readily understand why investors are attracted to unprofitable companies. Indeed, Corbus Pharmaceuticals Holdings ( NASDAQ:CRBP) stock is up 478% in the last year, providing strong gains for ...

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP rose 1.40% to $18.78 Friday, on what proved to be an all-around great ...

Corbus Pharmaceuticals Holdings ( (CRBP) ) has released its Q3 earnings. Here is a breakdown of the information Corbus Pharmaceuticals Holdings ...

An update from Corbus Pharmaceuticals ( (CRBP) ) is now available. Corbus Pharmaceuticals, an oncology and obesity-focused company, reported a ...

Completed Enrollment of Dose Escalation Part of Phase 1 Clinical Trial of its Next-Generation Nectin-4 Targeting ADC (CRB-701 ...

Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo ...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., ...

The Vallejo High School football team didn’t let the rainy weather bother its offense on Friday night en route to a 44-14 win over host De Anza. The Redhawks’ Sedrick Vaughn scored two ...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) has received an average recommendation of “Buy” from ...

The El Cerrito Gauchos may be 1-6, but they didn’t play like it at Corbus Field Friday night. El Cerrito came to Vallejo ...

Corbus Pharmaceuticals Holdings, Inc. (CRBP), a clinical-stage biopharma firm pioneering cannabis-based treatment to combat rare and chronic diseases, has broken out this year, making progress across ...